The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Cytokine therapeutics: lessons from interferonalpha.
Open accessAbstract
Cytokines are soluble proteins that allow for communication between cells and the external environment. Interferon (IFN) alpha, the first cytokine to be produced by recombinant DNA technology, has emerged as an important regulator of growth and differentiation, affecting cellular communication and signal transduction pathways as well as immunological control. This review focuses on the biological and clinical activities of the cytokine. Originally discovered as an antiviral substance, the efficacy of IFN-alpha in malignant, viral, immunological, angiogenic, inflammatory, and fibrotic diseases suggests a spectrum of interrelated pathophysiologies. The principles learned from in vivo studies will be discussed, particularly hairy cell leukemia, chronic myelogenous leukemia, certain angiogenic diseases, and hepatitis. After the surprising discovery of activity in a rare B-cell neoplasm, IFN-alpha emerged as a prototypic tumor suppressor protein that represses the clinical tumorigenic phenotype in some malignancies capable of differentiation. Regulatory agencies throughout the world have approved IFN-alpha for treatment of 13 malignant and viral disorders. The principles established with this cytokine serve as a paradigm for future development of natural proteins for human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Constantoulakis, P., Campbell, M., Felber, B. K., Nasioulas, G., Afonina, E., & Pavlakis, G. N. (1993) · Science · doi:10.1126/science.7680491 · Cited by 44
RetractedThe pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Oncogenes and signal transduction
Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., & Soltoff, S. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,694
Social controls on cell survival and cell death
Raff, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,604
Pestka, S., Langer, J. A., Zoon, K. C., & Samuel, C. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003455 · Cited by 1,825
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Carbon Monoxide: a Putative Neural Messenger
Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., & Snyder, S. H. (1993) · Science · doi:10.1126/science.7678352 · Cited by 1,563
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., & Bucala, R. (1993) · Nature · doi:10.1038/365756a0 · Cited by 999
Cadherins in cancer: implications for invasion and metastasis
Takeichi, M. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90029-p · Cited by 923
Increased cell division as a cause of human cancer.
Preston‐Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., & Henderson, B. E. (1990) · PubMed · Cited by 896
The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias
Epstein, F. H., Kurzrock, R., Gutterman, J. U., & Talpaz, M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191506 · Cited by 837
Self-citationAlpha Interferon for Induction of Remission in Hairy-Cell Leukemia
Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M., & Gutterman, J. U. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401053100104 · Cited by 820
Self-citation(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60034-2 · Cited by 800
Nathan, C., & Sporn, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.5.981 · Cited by 800
Folkman, J., & Shing, Y. (1992) · PubMed · Cited by 789
Cytoskeleton—Plasma Membrane Interactions
Luna, E. J., & Hitt, A. L. (1992) · Science · doi:10.1126/science.1439807 · Cited by 786
Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?
Romagnani, S. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90083-j · Cited by 780
Antioncogenes and human cancer.
Knudson, A. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10914 · Cited by 762
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90689-n · Cited by 659
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649
Talpaz, M., Kantarjian, H. M., McCredie, K., Trujillo, J. M., Keating, M. J., & Gutterman, J. U. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604243141701 · Cited by 647
Self-citationThe interferon system. A bird's eye view of its biochemistry.
Sen, G. C., & Lengyel, P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42719-6 · Cited by 620
Clinical toxicity of interferons in cancer patients: a review.
Quesada, J. R., Talpaz, M., Rios, A., Kurzrock, R., & Gutterman, J. U. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.2.234 · Cited by 596
Self-citationFibrogenic cytokines: the role of immune mediators in the development of scar tissue
Kovacs, E. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90107-5 · Cited by 590
The interferons. Mechanisms of action and clinical applications
Baron, S. (1991) · JAMA · doi:10.1001/jama.266.10.1375 · Cited by 569
Neuroendocrine-Immune Interactions
Epstein, F. H., & Reichlin, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291708 · Cited by 567
GUTTERMAN, J. U., BLUMENSCHEIN, G. R., ALEXANIAN, R., YAP, H.-Y., BUZDAR, A. U., CABANILLAS, F., HORTOBAGYI, G. N., HERSH, E. M., RASMUSSEN, S. L., HARMON, M., et al. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-399 · Cited by 497
Self-citationTumor Suppressor Genes: The Puzzle and the Promise
Sager, R. (1989) · Science · doi:10.1126/science.2574499 · Cited by 475
Zhuo, M., Small, S. A., Kandel, E. R., & Hawkins, R. D. (1993) · Science · doi:10.1126/science.8100368 · Cited by 467
Uyemura, K., Yamamura, M., Fivenson, D. F., Modlin, R. L., & Nickoloff, B. J. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371679 · Cited by 450
Apoptosis (the 1992 Frank Rose Memorial Lecture)
Wyllie, A. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.40 · Cited by 442
Parronchi, P., De Carli, M., Manetti, R., Simonelli, C., Sampognaro, S., Piccinni, M. P., Macchia, D., Maggi, E., Del Prete, G., & Romagnani, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.9.2977 · Cited by 427
Tanaka, N., Kawakami, T., & Taniguchi, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4531 · Cited by 423
Cytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F., & Coffman, R. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90044-l · Cited by 408
Lippman, S. M., Parkinson, D. R., Itri, L. M., Weber, R. S., Schantz, S. P., Ota, D. M., Schusterman, M. A., Krakoff, I. H., Gutterman, J. U., & Hong, W. K. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.235 · Cited by 393
Self-citationRestoration of HIV-Specific Cell-Mediated Immune Responses by Interleukin-12 in Vitro
Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Dolan, M. J., Hendrix, C. W., Wolf, S. F., & Shearer, G. M. (1993) · Science · doi:10.1126/science.7903123 · Cited by 384
Mandelli, F., Avvisati, G., Amadori, S., Boccadoro, M., Gernone, A., Lauta, V. M., Marmont, F., Petrucci, M. T., Tribalto, M., Vegna, M. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222005 · Cited by 382
Talpaz, M., Kantarjian, H., Kurzrock, R., Trujillo, J. M., & Gutterman, J. U. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-532 · Cited by 382
Self-citationDeletion of IRF-1 , Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia
Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., et al. (1993) · Science · doi:10.1126/science.8438156 · Cited by 381
Virus proteins that counteract host immune defenses
Gooding, L. R. (1992) · Cell · doi:10.1016/0092-8674(92)90259-f · Cited by 380
GUTTERMAN, J. U., FINE, S., QUESADA, J., HORNING, S. J., LEVINE, J. F., ALEXANIAN, R., BERNHARDT, L., KRAMER, M., SPIEGEL, H., COLBURN, W., et al. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-5-549 · Cited by 377
Self-citationHunter, T. (1993) · Cell · doi:10.1016/0092-8674(93)90528-x · Cited by 366
Barillari, G., Gendelman, R., Gallo, R. C., & Ensoli, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7941 · Cited by 356
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Interferon-α But Not AZT Suppresses HIV Expression in Chronically Infected Cell Lines
Poli, G., Orenstein, J. M., Kinter, A., Folks, T. M., & Fauci, A. S. (1989) · Science · doi:10.1126/science.2470148 · Cited by 328
Treatment of Chronic Hepatitis D with Interferon Alfa-2a
Farci, P., Mandas, A., Coiana, A., Lai, M. E., Desmet, V. J., Eyken, P. V., Gibo, Y., Caruso, L., Scaccabarozzi, S., Criscuolo, D., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401133300202 · Cited by 325
Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holderner, E., & Krakoff, I. H. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.241 · Cited by 320
Positive selection of candidate tumor-suppressor genes by subtractive hybridization.
Lee, S. W., Tomasetto, C., & Sager, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2825 · Cited by 319
McWhirter, J. R., & Wang, J. Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05797.x · Cited by 317
Regulation of the Cell Cycle by Calcium and Calmodulin
LU, K. P., & MEANS, A. R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-1-40 · Cited by 290
Neuronal differentiation factors/cytokines and synaptic plasticity
Patterson, P. H., & Nawa, H. (1993) · Cell · doi:10.1016/s0092-8674(05)80032-7 · Cited by 288
The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules
Grunwald, G. B. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90028-o · Cited by 287
Induction of Type I Diabetes by Interferon-α in Transgenic Mice
Stewart, T. A., Hultgren, B., Huang, X., Pitts-Meek, S., Hully, J., & MacLachlan, N. J. (1993) · Science · doi:10.1126/science.8100367 · Cited by 285
Tumour progression and the nature of cancer
Clark, W. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.375 · Cited by 282
Translocations, master genes, and differences between the origins of acute and chronic leukemias
Rabbitts, T. H. (1991) · Cell · doi:10.1016/0092-8674(91)90057-6 · Cited by 282
Treatment of hairy cell leukemia with recombinant alpha-interferon
Quesada, Jr., Hersh, E., Manning, J., Reuben, J., Keating, M., Schnipper, E., Itri, L., & Gutterman, J. (1986) · Blood · doi:10.1182/blood.v68.2.493.493 · Cited by 278
Self-citationThe growth arrest-specific gene, gas1, is involved in growth suppression
Del Sal, G. (1992) · Cell · doi:10.1016/0092-8674(92)90429-g · Cited by 275
Solal-Celigny, P., Lepage, E., Brousse, N., Reyes, F., Haioun, C., Leporrier, M., Peuchmaur, M., Bosly, A., Parlier, Y., Brice, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311253292203 · Cited by 268
Calabretta, B., Battini, R., Kaczmarek, L., de Riel, J. K., & Baserga, R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67137-6 · Cited by 261
Adhesion molecules in cancer: the role of integrins
Juliano, R. L., & Varner, J. A. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90030-t · Cited by 261
Neuropsychiatric Manifestations of Human Leukocyte Interferon Therapy in Patients With Cancer
Adams, F. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350070056026 · Cited by 260
TGF-beta: problems and prospects.
Sporn, M. B., & Roberts, A. B. (1990) · Cell Regulation · doi:10.1091/mbc.1.12.875 · Cited by 259
The multifunctional Ca2+/calmodulin-dependent protein kinases
Schulman, H. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90111-3 · Cited by 244
Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice.
Rich, B. E., Campos-Torres, J., Tepper, R. I., Moreadith, R. W., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.305 · Cited by 244
Lane, H. C., Davey, V., Kovacs, J. A., Feinberg, J., Metcalf, J. A., Herpin, B., Walker, R., Deyton, L., Davey, R. T., Falloon, J., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-11-805 · Cited by 228
Lu, C., & Kerbel, R. S. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.5.1281 · Cited by 224
Expression of Gene rrg Is Associated with Reversion of NIH 3Tt3 Transformed by LTR-c-H- ras
Contente, S., Kenyon, K., Rimoldi, D., & Friedman, R. M. (1990) · Science · doi:10.1126/science.1697103 · Cited by 221
Cellular adaptation in the origin and development of cancer.
Farber, E., & Rubin, H. (1991) · PubMed · Cited by 205
Antonelli, G., Currenti, M., Turriziani, O., & Dianzani, F. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.4.882 · Cited by 204
Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin
Rastinejad, F., Conboy, M. J., Rando, T. A., & Blau, H. M. (1993) · Cell · doi:10.1016/0092-8674(93)90320-p · Cited by 197
Structural relationship of human interferon alpha genes and pseudogenes
Henco, K., Brosius, J., Fujisawa, A., Fujisawa, J.-I., Haynes, J. R., Hochstadt, J., Kovacic, T., Pasek, M., Schamböck, A., Schmid, J., et al. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90401-2 · Cited by 197
Tumor-suppressor genes: news about the interferon connection.
Lengyel, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5893 · Cited by 196
Local expression of antiinflammatory cytokines in cancer.
Yamamura, M., Modlin, R. L., Ohmen, J. D., & Moy, R. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116256 · Cited by 196
Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice
Strober, W., & Ehrhardt, R. O. (1993) · Cell · doi:10.1016/0092-8674(93)80062-j · Cited by 188
Submembranous junctional plaque proteins include potential tumor suppressor molecules.
Tsukita, S., Itoh, M., Nagafuchi, A., Yonemura, S., & Tsukita, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.5.1049 · Cited by 179
Genomic Instability and Tumor Progression: Mechanistic Considerations
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60824-6 · Cited by 174
Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma
Smalley, R. V., Andersen, J. W., Hawkins, M. J., Bhide, V., O'Connell, M. J., Oken, M. M., & Borden, E. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211053271902 · Cited by 173
Autocrine Secretion—10 Years Later
Sporn, M. B., & Roberts, A. B. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-408 · Cited by 167
(1993) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60318-8 · Cited by 166
Ozer, H., George, S., Schiffer, C., Rao, K., Rao, P., Wurster-Hill, D., Arthur, D., Powell, B., Gottlieb, A., & Peterson, B. (1993) · Blood · doi:10.1182/blood.v82.10.2975.2975 · Cited by 165
VEGF/VPF: The angiogenesis factor found?
Klagsbrun, M., & Soker, S. (1993) · Current Biology · doi:10.1016/0960-9822(93)90073-w · Cited by 163
DIFFERENTIATION REQUIRES CONTINUOUS ACTIVE CONTROL
Blau, H. M. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.010025 · Cited by 150
Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene
Sager, R., Anisowicz, A., Neveu, M. J., Liang, P., & Sotiropoulou, G. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344495 · Cited by 149
Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.
Gishizky, M. L., Johnson-White, J., & Witte, O. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3755 · Cited by 148
Weinberg, R. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90177-s · Cited by 147
Induction of circulating IL-1 receptor antagonist by IFN treatment
Tilg, H., Mier, J. W., Vogel, W., Aulitzky, W. E., Wiedermann, C. J., Vannier, E. G., Huber, C. H., & Dinarello, C. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4687 · Cited by 136
Folkman, J., & Ingber, D. E. (1992) · PubMed · Cited by 135
Fabra, À., Nakajima, M., BUCANA, C. D., & Fidler, I. J. (1992) · Differentiation · doi:10.1111/j.1432-0436.1992.tb00504.x · Cited by 133
Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network
Hajjar, D. P., & Pomerantz, K. B. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.11.1644257 · Cited by 131
Ubiquitin in health and disease
Mayer, R. J., Arnold, J., László, L., Landon, M., & Lowe, J. S. (1991) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(91)90002-4 · Cited by 131
Small actin-binding proteins: the β-thymosin family
Nachmias, V. T. (1993) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(05)80008-0 · Cited by 130
Translation factors as effectors of cell growth and tumorigenesis
Sonenberg, N. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90076-3 · Cited by 125
Interferons in the Persistence, Pathogenesis, and Treatment of HIV Infection
Francis, M. L., Meltzer, M. S., & Gendelman, H. E. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.199 · Cited by 123
Ingber, D. E. (1992) · PubMed · Cited by 111
Altered cytokine production in black patients with keloids
McCauley, R. L., Chopra, V., Li, Y., Herndon, D. N., & Robson, M. C. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918154 · Cited by 109
Moses, M. A., & Langer, R. (1991) · Nature Biotechnology · doi:10.1038/nbt0791-630 · Cited by 108
Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus
Mozes, E., Kohn, L. D., Hakim, F. T., & Singer, D. S. (1993) · Science · doi:10.1126/science.8316860 · Cited by 107
Inheritance of Proliferative Breast Disease in Breast Cancer Kindreds
Skolnick, M. H., Cannon‐Albright, L., Goldgar, D. E., Ward, J. H., Marshall, C. J., Schumann, G. B., Hogle, H. H., McWhorter, W. P., Wright, E. C., Tran, T. D., et al. (1990) · Science · doi:10.1126/science.2270486 · Cited by 100
Human leukocyte interferon preparation blocks granulopoietic differentiation
Verma, D. S., Spitzer, G., Gutterman, J., Zander, A., McCredie, K., & Ka, D. (1979) · Blood · doi:10.1182/blood.v54.6.1423.1423 · Cited by 99
Self-citationOsteosarcoma in Adolescents and Young Adults
Lee, J. A., Lim, J., Jin, H. Y., Park, M., Park, H. J., Park, J. W., Kim, J. H., Kang, H. G., & Won, Y. (2021) · Cells · doi:10.3390/cells10102684 · Cited by 99
New Intracellular Targets for Therapeutic Drug Design
Brugge, J. S. (1993) · Science · doi:10.1126/science.8388123 · Cited by 97
Zinkernagel, R. M., Pircher, H., Ohashi, P. S., Oehen, S., Odermatt, B., Mak, T. W., Arnheiter, H., Bürki, K., & Hengartner, H. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00601.x · Cited by 97
Estrov, Z. E., Kurzrock, R., Wetzler, M., Kantarjian, H. M., Blake, M. E., Harris, D., Gutterman, J., & Talpaz, M. (1991) · Blood · doi:10.1182/blood.v78.6.1476.1476 · Cited by 96
Self-citationCell‐cell communication and growth control of normal and cancer cells: Evidence and hypothesis
Mesnil, M., Yamasaki, H., Balmain, A., Barrett, J. C., & Moses, H. L. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070103 · Cited by 96
Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.
Barnhill, R. L., & Levy, M. A. (1993) · PubMed · Cited by 93
N -Acetyl Cysteine Enhances the Response to Interferon-α in Chronic Hepatitis C: A Pilot Study
Beloqui, Ó., Prìeto, J., SUÁREZ, M., GIL, B., Qian, C. H., García, N., & Civeira, M. P. (1993) · Journal of Interferon Research · doi:10.1089/jir.1993.13.279 · Cited by 92
Aman, M., Rudolf, G., Goldschmitt, J., Aulitzky, W. E., Lam, C., Huber, C. G., & Peschel, C. (1993) · Blood · doi:10.1182/blood.v82.8.2371.2371 · Cited by 90
Shan, B., Vazquez, E., & Lewis, J. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07879.x · Cited by 88
Interferon beta in multiple sclerosis
Arnason, B. G. W. (1993) · Neurology · doi:10.1212/wnl.43.4.641 · Cited by 87
Regulation of gene expression and cell function by extracellular matrix.
Pl, J., Schmidhauser, C., & Mj, B. (1993) · PubMed · Cited by 86
Interferon in the management of chronic hepatitis B
Perrillo, R. P. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316785 · Cited by 84
Upadhyaya, G., Guba, S. C., Sih, S. A., Feinberg, A. P., Talpaz, M., Kantarjian, H. M., Deisseroth, A., & Emerson, S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115543 · Cited by 84
Roles of interferon produced in physiological conditions. A speculative review.
Bocci, V. A. (1988) · PubMed · Cited by 84
Gaspari, A. A., Fleisher, T. A., & Kraemer, K. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116682 · Cited by 81
Evolution of cancer genes as a mutation-driven process.
Temin, H. M. (1988) · PubMed · Cited by 80
Role of Growth Factors and Their Receptors in the Development and Progression of Melanoma
Shih, I., & Herlyn, M. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.76 · Cited by 79
Emerging Viruses: Defining the Rules for Viral Traffic
Morse, S. S. (1991) · Perspectives in biology and medicine · doi:10.1353/pbm.1991.0038 · Cited by 74
Melamed, D., Tiefenbrun, N., Yarden, A., & Kimchi, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5255 · Cited by 72
Zeng, F.-Y., Weiser, W. Y., Kratzin, H., Stahl, B., Karas, M., & Gabius, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1257 · Cited by 69
Pathways of Ras Function: Connections to the Actin Cytoskeleton
Prendergast, G. C., & Gibbs, W. W. (1993) · Advances in cancer research · doi:10.1016/s0065-230x(08)60314-0 · Cited by 66
Metcalf, D. (1989) · PubMed · Cited by 66
Haralson, M. A. (1993) · PubMed · Cited by 64
An Antiviral Soluble Form of the LDL Receptor Induced by Interferon
Fischer, D. G., Tal, N., Novick, D., Barak, S., & Rubinstein, M. (1993) · Science · doi:10.1126/science.8211145 · Cited by 63
Interferon treatment of cutaneous T‐cell lymphoma
Ross, C., TINGSGAARD, P. L. L. P. K., Jørgensen, H. L., & Vejlsgaard, G. L. (1993) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1993.tb01595.x · Cited by 61
The role of differentiation in the suppression of malignancy*
Harris, H. (1990) · Journal of Cell Science · doi:10.1242/jcs.97.1.5 · Cited by 61
Interferon-alpha induces the expression of the L-selectin homing receptor in human B lymphoid cells.
Evans, S. S., Collea, R. P., Appenheimer, M. M., & Gollnick, S. O. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.6.1889 · Cited by 50
Cytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F. M., & Coffman, R. L. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90202-u · Cited by 49
Antiviral therapy of hepatitis C — present and future
Hoofnagle, J. H., Bisceglie, A. M. D., & Shindo, M. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80438-6 · Cited by 48
Dhingra, K., Kurzrock, R., Kantarjian, H. M., Baine, R. M., Eastman, P., Ku, S., Gutterman, J. U., & Talpaz, M. (1992) · PubMed · Cited by 45
Self-citationInterferon‐α prevents endotoxin‐induced mortality in mice
Tzung, S.-P., Mahl, T. C., Lance, P., Andersen, V., & Cohen, S. A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221211 · Cited by 43
Interferon Treatments: How to Use an Endogenous System as a Therapeutic Agent
DIANZANI, F. (1992) · Journal of Interferon Research · doi:10.1089/jir.1992.1992.109 · Cited by 43
Montminy, M. (1993) · Science · doi:10.1126/science.8397444 · Cited by 41
Interferons alpha and beta as cellular regulatory molecules.
Tamm, I., Sl, L., Pfeffer, L. M., & Sehgal, P. B. (1987) · PubMed · Cited by 29
Noda, M. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344483 · Cited by 24
Wang, C., Constantinescu, S. N., MacEwan, D. J., Strulovici, B., Dekker, L. V., Parker, P. J., & Pfeffer, L. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6944 · Cited by 21
Potential role of the viral protease in human immunodeficiency virus type 1 associated pathogenesis
Shoeman, R. L., Höner, B., Mothes, E., & Traub, P. (1992) · Medical Hypotheses · doi:10.1016/0306-9877(92)90071-j · Cited by 15
Skurkovich, S. V., Skurkovich, B., & Bellanti, J. A. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90031-0 · Cited by 14
Adjuvant interferon treatment in human osteosarcoma
Strander, H. A., Bauer, H. C. F., Brosjö, O., Andris Kreicbergs, A., Lindholm, J., Nilsonne, U., Silfverswärd, C., & Szamosi, A. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3518-8_5 · Cited by 13
A discriminant function analysis of various interferon parameters among alcoholics and heavy smokers
Windle, M. T., Mondul, T., Whitney, R. B., Cummings, K. M., Stadler, I., & Chadha, K. C. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90066-y · Cited by 9
Cited by
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847
Metadata
- Authors
- Gutterman, J. U.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-02-15
- Volume
- 91
- Issue
- 4
- Pages
- 1198-1205
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2038428454
- Cited by
- 703
- References
- 144
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.